Luo (peuple d'Afrique) -- Monnaie. : Bitter money : cultural economy and some African meanings of forbidden commodities / Parker Shipton
1989
1
Monnaie -- Mexique -- Histoire. : Moneda, seudomonedas y circulación monetaria en las economías de México / Ruggiero Romano ; traducción de Arauco Chihuailaf
1998
1
Monnaie -- Rome -- Histoire. : The metallurgy of Roman silver coinage : from the reform of Nero to the reform of Trajan / Kevin Butcher and Matthew Ponting ; with contributions by Jane Evans, Vanessa Pashley and Christopher Somerfield
2014
1
Monnaie -- Russie. : Transforming financial systems in the Baltics, Russia, and other countries of the former Soviet Union / editors, Malcolm Knight, Arne B. Petersen, Robert T. Price
Monnaies de réserve. : Financial stability in dollarized economies / Anne-Marie Gulde [and others]
2004
1
Monnaies internationales. : Nation-states and money : the past, present and future of national currencies / edited by Emily Gilbert and Eric Helleiner
1999
1
Monnaies romaines. : The metallurgy of Roman silver coinage : from the reform of Nero to the reform of Trajan / Kevin Butcher and Matthew Ponting ; with contributions by Jane Evans, Vanessa Pashley and Christopher Somerfield
Mono Lake (Calif.) : The Mono Basin ecosystem : effects of changing lake level / Mono Basin Ecosystem Study Committee, Board on Environmental Studies and Toxicology, Commission on Physical Sciences, Mathematics, and Resources, National Research Council
An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
